D. Schiff
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
.
Cancer.
2019
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572
.
Cancer.
2018
Contact
full name
D.
Schiff
Quick Info
Collaboration
Co-author network
Map of science